RSS-Feed abonnieren
DOI: 10.1055/s-0030-1268708
Type and Timing of Ventilation in the First Postnatal Week is Associated with Bronchopulmonary Dysplasia/Death
Publikationsverlauf
Publikationsdatum:
16. November 2010 (online)
![](https://www.thieme-connect.de/media/ajp/201104/lookinside/thumbnails/10.1055-s-0030-1268708-1.jpg)
ABSTRACT
The type and timing of respiratory support in the first week affecting bronchopulmonary dysplasia (BPD)/death have not been evaluated. We compared outcomes of premature infants on nasal intermittent positive pressure ventilation (NIPPV) or nasal continuous positive airway pressure (NCPAP) to those on endotracheal tube (ETT). We retrospectively reviewed data (1/2004 to 6/2009) of infants ≤ 30 weeks' gestational age (GA) who received NIPPV in the first postnatal week. National Institutes of Health consensus definition was used for BPD. Infants were categorized into three groups based on their being on a particular respiratory support mode for majority of days in the first week. There was no difference in the mean GA and body weight in the three groups: ETT (n = 65; 26.7 weeks; 909 g), NIPPV (n = 66; 27.1 weeks; 948 g), and NCPAP (n = 33; 27.4 weeks; 976 g). Use of surfactant was significantly different. In multivariate analysis, compared with ETT, NIPPV (p < 0.02) and NCPAP (p < 0.01) groups were less likely to have BPD/death. Infants on ETT (n = 97) during 1 to 3 days were more likely to have BPD/death compared with those on NIPPV (n = 38): 67% versus 47% (p = 0.035). Infants on ETT (n = 30) during 4 to 7 days were more likely to have BPD/death compared with those extubated to NIPPV (n = 36): 87 versus 53% (p = 0.003). Extubation to NIPPV or NCPAP in the first postnatal week is associated with decreased probability of BPD/death.
KEYWORDS
Premature newborn - noninvasive ventilation - NIPPV - NCPAP
REFERENCES
- 1 Bhandari A, Bhandari V. Pitfalls, problems, and progress in bronchopulmonary dysplasia. Pediatrics. 2009; 123 1562-1573
- 2 Bhandari A, Bhandari V. Pathogenesis, pathology and pathophysiology of pulmonary sequelae of bronchopulmonary dysplasia in premature infants. Front Biosci. 2003; 8 e370-e380
- 3 Gupta S, Sinha S K, Donn S M. Ventilatory management and bronchopulmonary dysplasia in preterm infants. Semin Fetal Neonatal Med. 2009; 14 367-373
- 4 Gonzaga A D, Duque Figueira B B, Sousa J M, de Carvalho W B. [Duration of mechanical ventilation and development of bronchopulmonary dysplasia]. Rev Assoc Med Bras. 2007; 53 64-67
- 5 Chen Y, Han Y K, Ye Z Z, Lu G J. [Risk factors for bronchopulmonary dysplasia in neonates with respiratory distress syndrome]. Zhongguo Dang Dai Er Ke Za Zhi. 2007; 9 15-18
- 6 Bhandari V, Bergqvist L L, Kronsberg S S, Barton B A, Anand K J. NEOPAIN Trial Investigators Group . Morphine administration and short-term pulmonary outcomes among ventilated preterm infants. Pediatrics. 2005; 116 352-359
- 7 Van Marter L J, Dammann O, Allred E N Developmental Epidemiology Network Investigators et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J Pediatr. 2002; 140 171-176
- 8 Bhutani V K, Abbasi S. Relative likelihood of bronchopulmonary dysplasia based on pulmonary mechanics measured in preterm neonates during the first week of life. J Pediatr. 1992; 120 (4 Pt 1) 605-613
- 9 Cunha G S, Mezzacappa-Filho F, Ribeiro J D. Risk factors for bronchopulmonary dysplasia in very low birth weight newborns treated with mechanical ventilation in the first week of life. J Trop Pediatr. 2005; 51 334-340
- 10 May C, Kavvadia V, Dimitriou G, Greenough A. A scoring system to predict chronic oxygen dependency. Eur J Pediatr. 2007; 166 235-240
- 11 Van Marter L J, Allred E N, Pagano M et al.. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000; 105 1194-1201
- 12 Sekar K C, Corff K E. To tube or not to tube babies with respiratory distress syndrome. J Perinatol. 2009; 29 (Suppl 2) S68-S72
- 13 Verder H, Bohlin K, Kamper J, Lindwall R, Jonsson B. Nasal CPAP and surfactant for treatment of respiratory distress syndrome and prevention of bronchopulmonary dysplasia. Acta Paediatr. 2009; 98 1400-1408
- 14 Bancalari E, del Moral T. Continuous positive airway pressure: early, late, or stay with synchronized intermittent mandatory ventilation?. J Perinatol. 2006; 26 (Suppl 1) S33-S37 discussion S43-S45
- 15 Morley C J, Davis P G, Doyle L W, Brion L P, Hascoet J M, Carlin J B. COIN Trial Investigators . Nasal CPAP or intubation at birth for very preterm infants. N Engl J Med. 2008; 358 700-708
- 16 Ramanathan R, Sardesai S. Lung protective ventilatory strategies in very low birth weight infants. J Perinatol. 2008; 28 (Suppl 1) S41-S46
- 17 Khalaf M N, Brodsky N, Hurley J, Bhandari V. A prospective randomized, controlled trial comparing synchronized nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as modes of extubation. Pediatrics. 2001; 108 13-17
- 18 Kugelman A, Feferkorn I, Riskin A, Chistyakov I, Kaufman B, Bader D. Nasal intermittent mandatory ventilation versus nasal continuous positive airway pressure for respiratory distress syndrome: a randomized, controlled, prospective study. J Pediatr. 2007; 150 521-526, 526, e1
- 19 Bhandari V, Gavino R G, Nedrelow J H et al.. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS. J Perinatol. 2007; 27 697-703
- 20 Ehrenkranz R A, Walsh M C, Vohr B R National Institutes of Child Health and Human Development Neonatal Research Network et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics. 2005; 116 1353-1360
- 21 Papile L A, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978; 92 529-534
- 22 Volpe J J. Intracranial hemorrhage: germinal matrix-intraventricular hemorrhage of the premature infant. In: Volpe J J, ed. Neurology of the Newborn. 4th ed. Philadelphia: WB Saunders; 2001: 435-447
- 23 Bell M J, Ternberg J L, Feigin R D et al.. Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging. Ann Surg. 1978; 187 1-7
- 24 Anonymous . An international classification of retinopathy of prematurity. Pediatrics. 1984; 74 127-133
- 25 Bhandari V. Nasal intermittent positive pressure ventilation in the newborn: review of literature and evidence-based guidelines. J Perinatol. 2010; 30 505-512
- 26 Laughon M, Allred E N, Bose C ELGAN Study Investigators et al. Patterns of respiratory disease during the first 2 postnatal weeks in extremely premature infants. Pediatrics. 2009; 123 1124-1131
- 27 De Paoli A G, Davis P G, Lemyre B. Nasal continuous positive airway pressure versus nasal intermittent positive pressure ventilation for preterm neonates: a systematic review and meta-analysis. Acta Paediatr. 2003; 92 70-75
- 28 Strong R M, Passy V. Endotracheal intubation. Complications in neonates. Arch Otolaryngol. 1977; 103 329-335
- 29 Kwinta P, Grudzień A, Pawlik D, Olechowski W, Lauterbach R, Pietrzyk J J. [Prevalence and risk factors of bronchopulmonary dysplasia among extremely low birth weight newborns of regional birth cohort of south-east Poland]. Przegl Lek. 2009; 66 14-20
- 30 Bhering C A, Mochdece C C, Moreira M E, Rocco J R, Sant'Anna G M. Bronchopulmonary dysplasia prediction model for 7-day-old infants. J Pediatr (Rio J). 2007; 83 163-170
- 31 Santin R, Brodsky N, Bhandari V. A prospective observational pilot study of synchronized nasal intermittent positive pressure ventilation (SNIPPV) as a primary mode of ventilation in infants > or = 28 weeks with respiratory distress syndrome (RDS). J Perinatol. 2004; 24 487-493
- 32 Sai Sunil Kishore M, Dutta S, Kumar P. Early nasal intermittent positive pressure ventilation versus continuous positive airway pressure for respiratory distress syndrome. Acta Paediatr. 2009; 98 1412-1415
- 33 Akram Khan M, Kuzma-O'Reilly B, Brodsky N L, Bhandari V. Site-specific characteristics of infants developing bronchopulmonary dysplasia. J Perinatol. 2006; 26 428-435
- 34 Hentschel J, Berger T M, Tschopp A, Müller M, Adams M, Bucher H U. Swiss Neonatal Network . Population-based study of bronchopulmonary dysplasia in very low birth weight infants in Switzerland. Eur J Pediatr. 2005; 164 292-297
- 35 Tapia J L, Agost D, Alegria A NEOCOSUR Collaborative Group et al. Bronchopulmonary dysplasia: incidence, risk factors and resource utilization in a population of South American very low birth weight infants. J Pediatr (Rio J). 2006; 82 15-20
- 36 Van Marter L J. Epidemiology of bronchopulmonary dysplasia. Semin Fetal Neonatal Med. 2009; 14 358-366
Vineet BhandariM.D. D.M.
Division of Perinatal Medicine, Department of Pediatrics, Yale University School of Medicine
333 Cedar Street, LCI 401B, New Haven, CT 06520-8064
eMail: vineet.bhandari@yale.edu